Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-16

Clinical Trial Update: 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 5% lidocaine ointment for vulvar vestibulitis was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine 5% ointment (lidocaine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Vulvar Vestibulitis | Phase 2 | Status: TERMINATED | Results posted: 2012-07-16